Avonex (interferon beta-1a) for multiple sclerosis

January 1996

The FDA will soon approve Avonex (interferon beta-1a) for multiple sclerosis.

It's a beta-interferon...similar to Betaseron.

Both Avonex and Betaseron help reduce the frequency of relapses in patients with the relapsing-remitting form of MS. In addition, Avonex also slows the progression of the disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

momentum building for providing "Continuity of Care
Anticoagulants patients monitor their own warfarin therapy AT HOME
Anticoagulants using the clot-buster t-PA (Activase) for stroke
Anticoagulants ReoPro (abciximab) to inhibit blood clotting
approving the antihistamine clemastine (Tavist) for cold symptoms
Diabetes Bayer is finally launching Precose (acarbose)
Hematology & Oncology limit tamoxifen use to 5 years
Hematology & Oncology 20 mg Nolvadex (tamoxifen) tablet
Oral Health some people get fewer canker sores when they switch to a toothpaste that DOESN'T contain sodium lauryl sulfate (SLS)
Oral Health Trental (pentoxifylline) for SEVERE cases of recurrent canker sores
Cardiology the recent concerns about calcium blockers decreasing survival
Cardiology new calcium channel blocker for hypertension called Sular (nisoldipine)
Ritalin (methylphenidate) for ADHD
Cholesterol proof that lowering cholesterol reduces the risk of a first heart attack
Cholesterol one cholesterol test isn't enough to determine a patient's cholesterol level
Avonex (interferon beta-1a) for multiple sclerosis
some physicians will prescribe TWO nicotine patches a day

Avonex (interferon beta-1a) for multiple sclerosis

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents